H.R. 5160 (PCS) - Stem Cell Therapeutic and Research Reauthorization Act of 2025
Sentiment Mix
Geography
Expert Signals
GovInfo (GPO) (Official) - Congressional Bills
source • 10 mentions
AI-Generated Claims
Generated from linked receipts; click sources for full context.
6238 (RFS) - NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone Act.
Supported by 1 story
5034 (IS) - Medicare Advantage Supplemental Benefits Transparency Act of 2026.
Supported by 1 story
8790 (RFS) - Next-Generation Geothermal Research and Development Act.
Supported by 1 story
5033 (IS) - Judicial FOIA Expansion Act.
Supported by 1 story
6330 (RFS) - Federal Relocation Payment Improvement Act.
Supported by 1 story
5578 (PCS) - Expanding Whistleblower Protections for Contractors Act of 2026.
Supported by 1 story
4348 (PCS) - An Act To reauthorize the Kay Hagan Tick Act, and for other purposes..
Supported by 1 story
1703 (RFS) - Choices for Increased Mobility Act of 2026.
Supported by 1 story
Summary
**Summary:** The Stem Cell Therapeutic and Research Reauthorization Act of 2025 (H.R. 5160) is a bill aimed at reauthorizing stem cell research and therapeutic activities. **Why It Matters:** This legislation aims to support the development and application of stem cells in medical treatments
Related Events
H.R. 9770 (EH) - An Act Making continuing appropriations for fiscal year 2027, and for other purposes.
Uncategorized • 7/23/2026
S. 5035 (IS) - National Coordination on Resilience for Security Act of 2026
Policy & Regulation • 7/23/2026
H.R.7008
Uncategorized • 7/23/2026
H.Con.Res.113
Uncategorized • 7/22/2026
GE Aerospace and Magellan plan Canadian F414 engine MRO capability if Ottawa selects Saab Gripen E for RCAF fighter fleet - Defence Industry Europe
Uncategorized • 7/23/2026